|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization | |
| Stock-based compensation expense | |
| Non-cash operating lease expense | |
| Amortization of debt discounts | |
| Changes in fair value of financial instruments | |
| Loss on debt extinguishment | |
| Other | |
| Changes in operating assets and liabilities: | |
| Accounts receivable | |
| Supplies | |
| Prepaid expenses and other current assets | |
| Other assets | |
| Accounts payable | |
| Accrued expenses and other liabilities | |
| Net cash provided by (used in) operating activities | |
| Cash flows from investing activities | |
| Maturities of marketable securities | |
| Purchases of marketable securities | |
| Purchases of property and equipment | |
| Net cash provided by (used in) investing activities | |
| Cash flows from financing activities | |
| Payments made on finance lease obligations | |
| Operating leases | |
| Finance leases | |
| Property and equipment included in accounts payable and accrued liabilities | |
| Conversion of 2025 Convertible Notes and accrued interest to common stock upon initial public offering | |
| 2018 Convertible Notes | |
| 2025 Convertible Notes | |
| Non-cash considerations | |
| Deferred offering costs, accrued but not paid | |
| Conversion of redeemable convertible preferred stock to common stock upon initial public offering | |
| Exercise of warrants upon initial public offering | |
| Reclassification of deferred offering costs to additional paid-in capital upon initial public offering | |
| Deemed dividend from Series D redeemable convertible preferred stock | |
| Proceeds from exercise of stock options | |
| Payment of taxes withheld from net settlement of exercised options and vested RSUs | |
| Payment of deferred offering costs | |
| Payment of third-party debt issuance costs | |
| Proceeds from the 2023 term loan, net of issuance costs | |
| Repurchase of common stock | |
| Repayment of the Original Term Loans | |
| Issuance of the 2025 Convertible Notes, net of issuance costs | |
| Issuance of the 2025 Warrants | |
| Payments of 2023 term loan amendment fee | |
| Proceeds from initial public offering, net of underwriting discounts and commissions | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |
| Cash, cash equivalents, and restricted cash at beginning of period | |
| Cash, cash equivalents, and restricted cash at end of period | |
| Supplemental disclosure of cash flow information | |
| Interest paid | |
| Supplemental disclosure of non-cash activity | |
| Operating cash flow used for operating leases | |
| Operating cash flow used for finance leases |
Loading...
